Issues such as insufficient funding for public healthcare and corruption will continue to hamper the development of legitimate medicines market.Key Trends & Developments- In May 2012, Serbian drugmaker Hemofarm, a subsidiary of German firm Stada Arzneimittel, started direct sales to state-run pharmacies, which allows it to avoid some wholesalers.